<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2024 (5) TMI 1143 - JAMMU AND KASHMIR AND LADAKH HIGH COURT</title>
    <link>https://www.taxtmi.com/caselaws?id=753090</link>
    <description>The J&amp;amp;K and Ladakh HC held that diagnostic kits are devices rather than medicines under the Drugs and Cosmetics Act, 1940. While Section 3(b)(i) covers medicines for diagnosis and Section 3(b)(iv) covers diagnostic devices, devices only qualify as drugs if notified by the Central Government in the Official Gazette. Since the petitioners failed to demonstrate such notification for the diagnostic kits in question, they cannot be treated as drugs under Section 3(b)(iv). Consequently, these kits attract 12.5% VAT under Entry 165 of Schedule D rather than the 4% rate applicable to drugs under Entry 48 of Schedule C, unless subsequently notified as drugs by the Central Government.</description>
    <language>en-us</language>
    <pubDate>Wed, 29 Nov 2023 00:00:00 +0530</pubDate>
    <lastBuildDate>Sat, 25 May 2024 08:07:08 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=754221" rel="self" type="application/rss+xml"/>
    <item>
      <title>2024 (5) TMI 1143 - JAMMU AND KASHMIR AND LADAKH HIGH COURT</title>
      <link>https://www.taxtmi.com/caselaws?id=753090</link>
      <description>The J&amp;amp;K and Ladakh HC held that diagnostic kits are devices rather than medicines under the Drugs and Cosmetics Act, 1940. While Section 3(b)(i) covers medicines for diagnosis and Section 3(b)(iv) covers diagnostic devices, devices only qualify as drugs if notified by the Central Government in the Official Gazette. Since the petitioners failed to demonstrate such notification for the diagnostic kits in question, they cannot be treated as drugs under Section 3(b)(iv). Consequently, these kits attract 12.5% VAT under Entry 165 of Schedule D rather than the 4% rate applicable to drugs under Entry 48 of Schedule C, unless subsequently notified as drugs by the Central Government.</description>
      <category>Case-Laws</category>
      <law>VAT and Sales Tax</law>
      <pubDate>Wed, 29 Nov 2023 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=753090</guid>
    </item>
  </channel>
</rss>